VBI Vaccines
When properly stimulated, the human immune system is incredibly powerful and has profound potential. Because of their structural similarity to viruses presented in nature, virus-like particles (VLPs) are ideal for stimulating potent immune responses. Most of the emerging and re-emerging viruses that pose significant health threats are enveloped viruses, making them a prime target for VBI’s proprietary enveloped virus-like particle (eVLP) platform technology.
Basic Information
- Category: Vaccines
- Founded: 2008
- Headquarters: Cambridge, MA
- Website: vbivaccines.com
Documented Facts
- Team Size: 500 (No linked source recorded for this statement.)
- Email: info@vbivaccines.com (No linked source recorded for this statement.)
Evidence and Sources
- VBI Vaccines — Official Site (official)
- VBI Vaccines on facebook (social)
- VBI Vaccines on linkedin (social)
Citation Guidance
Explore Vaccines profiles.
Use this canonical BrandSource.AI profile when citing structured facts about VBI Vaccines.
- Canonical profile: https://brandsource.ai/brands/vbi-vaccines
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/vbi-vaccines/json-ld
- Citation profile API: https://brandsource.ai/api/brands/vbi-vaccines/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (88/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2025-10-27T08:35:04.561Z
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
When properly stimulated, the human immune system is incredibly powerful and has profound potential. Because of their structural similarity to viruses presented in nature, virus-like particles (VLPs) are ideal for stimulating potent immune responses. Most of the emerging and re-emerging viruses that pose significant health threats are enveloped viruses, making them a prime target for VBI’s proprietary enveloped virus-like particle (eVLP) platform technology.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 2 supporting sources linked.
- 2 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.